drugset / Trial / NCT07271056

Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches

NCT07271056

Completed 56 enrolled Benha University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluated whether preoperative sublingual misoprostol can enhance the effectiveness and safety of niche resection in patients with symptomatic uterine niche.

Timeline

Start
2025-02-11
Primary completion
2025-07-30
Completion
2025-10-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 200 ug Subcutaneous

Indications

No indication recorded.